1.ªÑªF·|¨Mij¤é:114/06/12
2.³\¥i±q¨ÆÄv·~¦æ¬°¤§¸³¨Æ©m¦W¤Î¾ºÙ:
¸³ ¨Æ ªL¸s
¸³ ¨Æ ²·þ¾Ë
¸³ ¨Æ ÂåºÍÂåÃĬì§Þ(ªÑ)¤½¥q ¥Nªí¤H¡G¦¶¥ì¤å
¸³ ¨Æ ³¢²±§U
¸³ ¨Æ §d¤Ñ½à
¸³ ¨Æ ®}¤å¸R
¿W¥ß¸³¨Æ ªL¥É¼e
¿W¥ß¸³¨Æ ±i®¶ªZ
¿W¥ß¸³¨Æ ½Ñ¥ò±j
3.³\¥i±q¨ÆÄv·~¦æ¬°¤§¶µ¥Ø:
(1)¸³¨Æ ªL¸s
¥þºÖ¥Íª«¬ì§Þ(ªÑ)¤½¥q¸³¨Æªø/§ë¸êªø
©yÄ¥ÍÂå(ªÑ)¤½¥q¸³¨Æªø
¦w´I¸ê¥»(ªÑ)¤½¥q¸³¨Æªø
´I¨¹¤H¹Ø«OÀI(ªÑ)¤½¥q¿W¥ß¸³¨Æ
§»ùÖ´¼·s(ªÑ)¤½¥q¿W¥ß¸³¨Æ
º~±d-KYªk¤H¸³¨Æ¥Nªí¤H
(2)¸³¨Æ ²·þ¾Ë
¥xºÍÂåÃĬãµo(©ø¤s)¦³¤½¥q°õ¦æ¸³¨Æ
TaiRx US, Inc. Á`¸g²z/¸³¨Æ
TaiRx Pharmaceuticals Co., Ltd.ªk¤H¸³¨Æ¥Nªí¤H
ºëºÍÂåÃĬì§Þ(ªÑ)¤½¥q¸³¨Æªø
ÂåºÍÂåÃĬì§Þ(ªÑ)¤½¥q¸³¨Æªø
¥ýª¾¥Íª«¬ì§Þ(ªÑ)¤½¥q¸³¨Æªø
^Äݶ}°Ò¸s®q°Ó¥ýª¾¥Íª«¬ì§Þ(ªÑ)¤½¥q¸³¨Æªøº[¥xÆW¤À¤½¥q¸g²z¤H
^Äݶ}°Ò¸s®q°Ó¥ýÅX¥Í§Þ(ªÑ)¤½¥q¸³¨Æ
¥ýÅX¥Í§Þ(ªÑ)¤½¥q¸³¨Æªk¤H¸³¨Æ¥Nªí¤H
¼w¥þÃÄ«~(¦¿Ä¬)ªÑ¥÷¦³¤½¥qªk¤H¸³¨Æ¥Nªí¤H
(3)¸³¨Æ ÂåºÍÂåÃĬì§ÞªÑ¥÷¦³¤½¥q ¥Nªí¤H¡G¦¶¥ì¤å
TaiRx US, Inc.¸³¨Æ
¥xºÍÂåÃĬãµo(©ø¤s)¦³¤½¥qÁ`¸g²z
ºëºÍÂåÃĬì§Þ(ªÑ)¤½¥q¸³¨Æ
ÂåºÍÂåÃĬì§Þ(ªÑ)¤½¥q¸³¨Æ
(4)¸³¨Æ ³¢²±§U
¤¤°êÂåÃĤj¾ÇÃľǰ|ÃľǨtÁ¿®y±Ð±Â
¤j¤¯¬ì§Þ¤j¾Ç¸³¨Æ
¦Ê¼Ú¥K¬ì¬ã(ªÑ)¤½¥q¸³¨Æ
(5)¸³¨Æ §d¤Ñ½à
°]¹Îªk¤HÂåÃĤu·~§Þ³Nµo®i¤¤¤ßºÊ¹î¤H
°ê¥ß¦¨¥\¤j¾Ç¦WÅA±Ð±Âº[Ý¥ô±Ð±Â
´¼°ò¬ì§Þ¶}µo(ªÑ)¤½¥q¿W¥ß¸³¨Æ
(6)¸³¨Æ ®}¤å¸R
¥þºÖ¥Íª«¬ì§Þ(ªÑ)¤½¥qÁ`¸g²z
^Äݶ}°Ò¸s®q°Ó¥ýª¾¥Íª«¬ì§Þ(ªÑ)¤½¥q¸³¨Æ
(7)¿W¥ß¸³¨Æ ªL¥É¼e
·NÄË-KY¿W¥ß¸³¨Æ
´¹»¨¬ì§Þ¿W¥ß¸³¨Æ
®mµ{¬ì§ÞºÊ¹î¤H
(8)¿W¥ß¸³¨Æ ±i®¶ªZ
¤ß®®¥ÍÂå(ªÑ)¤½¥q¿W¥ß¸³¨Æ
¦w°ò¥Í§Þ(ªÑ)¤½¥q¿W¥ß¸³¨Æ
¦w¨¹¥Í§Þ(ªÑ)¤½¥q¸³¨Æ
4.³\¥i±q¨ÆÄv·~¦æ¬°¤§´Á¶¡:¥ô¾¥»¤½¥q¸³¨ÆÂ¾°È´Á¶¡¡C
5.¨Mij±¡§Î¡]½Ð¨Ì¤½¥qªk²Ä209±ø»¡©úªí¨Mµ²ªG¡^:
¸gªÑªF±`·|¤wµo¦æªÑ¥÷Á`¼Æ¹L¥b¼ÆªÑªF¥X®u¡A¥X®uªÑªFªí¨MÅv¤T¤À¤§¤G¥H¤W¦P·N¡A
·Ó®×³q¹L¡C
6.©Ò³\¥i¤§Äv·~¦æ¬°¦pÄݤj³°¦a°Ï¨Æ·~¤§Àç·~ªÌ¡A¸³¨Æ©m¦W¤Î¾ºÙ¡]«DÄݤj³°¦a°Ï¨Æ·~¤§
Àç·~ªÌ¡A¥H¤UÄæ¦ì½Ð¿é¤£¾A¥Î¡^:
¸³¨Æ ²·þ¾Ë
¸³¨Æ ¦¶¥ì¤å
7.©Ò¾á¥ô¸Ó¤j³°¦a°Ï¨Æ·~¤§¤½¥q¦WºÙ¤Î¾°È:
¸³¨Æ ²·þ¾Ë¡G
¥xºÍÂåÃĬãµo(©ø¤s)¦³¤½¥q°õ¦æ¸³¨Æ
¼w¥þÃÄ«~(¦¿Ä¬)ªÑ¥÷¦³¤½¥qªk¤H¸³¨Æ¥Nªí¤H
¸³¨Æ ¦¶¥ì¤å¡G¥xºÍÂåÃĬãµo(©ø¤s)¦³¤½¥qÁ`¸g²z
8.©Ò¾á¥ô¸Ó¤j³°¦a°Ï¨Æ·~¦a§}:
¥xºÍÂåÃĬãµo(©ø¤s)¦³¤½¥q¡G
¦¿Ä¬¬Ù©ø¤s¥«¶}µo°Ï¬K¦°¸ô168¸¹«ÒÄ_ª÷¿Ä¤j·H9¼h9502«Ç¡C
¼w¥þÃÄ«~(¦¿Ä¬)ªÑ¥÷¦³¤½¥q¡G
¦¿Ä¬¬Ù©ø¤s¥«³°®aÂíª÷¶§¦è¸ô191¸¹
9.©Ò¾á¥ô¸Ó¤j³°¦a°Ï¨Æ·~Àç·~¶µ¥Ø:·sÃħ޳N¬ãµo¤Î¾P°âÂåÃÄ«~¡C
10.¹ï¥»¤½¥q°]°È·~°È¤§¼vÅTµ{«×:µL¡C
11.¸³¨Æ¦p¦³¹ï¸Ó¤j³°¦a°Ï¨Æ·~±q¨Æ§ë¸êªÌ¡A¨ä§ë¸êª÷ÃB¤Î«ùªÑ¤ñ¨Ò:¤£¾A¥Î¡C
12.¨ä¥LÀ³±Ô©ú¨Æ¶µ:µL¡C
<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸>